| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |